Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03454802
Other study ID # 619909
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 1, 2018
Est. completion date October 1, 2020

Study information

Verified date September 2021
Source Region MidtJylland Denmark
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim is to describe the physiological background for PLR and the interpretation of a PLR manoeuvre. The protocol entails the measurement of stroke volume (SV) at baseline (semirecumbent patient position), during PLR and after returning to semirecumbent position. Simultaneously blood pressure (BP), pulse rate (PR), pulse oximetric saturation (SpO2) and ECG are recorded. The procedure is performed in ten normal subjects, ten patients recruited in the cardiology outpatient department and ten critically ill patients under analgosedation in the ICU. Analysis includes changes in measured variables and heart rate variability in the frequency domain during the three phases of the experiment.


Description:

See above


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date October 1, 2020
Est. primary completion date October 1, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: Consenting after written and oral information Exclusion Criteria: Contraindications to PLR: intracranial or abdominal hypertension

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Passive Leg Raising
See above

Locations

Country Name City State
Denmark Regionshospitalet Silkeborg Silkeborg Midtjylland

Sponsors (2)

Lead Sponsor Collaborator
Region MidtJylland Denmark Edwards Lifesciences

Country where clinical trial is conducted

Denmark, 

References & Publications (1)

Monnet X, Rienzo M, Osman D, Anguel N, Richard C, Pinsky MR, Teboul JL. Passive leg raising predicts fluid responsiveness in the critically ill. Crit Care Med. 2006 May;34(5):1402-7. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in cardiovascular variables I stroke volume, SV (mL) 10 minutes
Primary Changes in cardiovascular variables II pulse rate, PR (min^-1) 10 minutes
Primary Changes in cardiovascular variables III blood pressure, BP (mmHg) 10 minutes
Primary Changes in cardiovascular variables IV pulse oximetric saturation, SpO2 (%) 10 minutes
Primary Changes in HRV frequency domain variables V Heart rate variability, HRV, variables in frequency domain (low frequency, LF, 0.04-0.15 Hz, high frequency, HF, 0.15-0.4 Hz) 10 minutes
Primary Changes in HRV frequency domain variables VI HRV absolute power (ms^2, natural logarithm transformed values of absolute powers of very low frequency, VLF, LF, and HF bands) 10 minutes
Primary Changes in HRV frequency domain variables VII HRV relative power (absolute power/total power) 10 minutes
Primary Changes in HRV frequency domain variables VIII HRV normalized power (%, normalized units, n.u.) 10 minutes
Primary Changes in HRV frequency domain variables IX HRV total power given by VLF + HF + LF (ms2) and LF/HF ratio. 10 minutes
See also
  Status Clinical Trial Phase
Recruiting NCT03882580 - Reporting, Evaluating, Preventing and Treating the Cardiotoxicity Induced by Anticancer Drugs During a Specific Cardio-oncology Consult and Follow up in Routine Care
Completed NCT01954056 - Hydrocortisone for Term Hypotension Phase 3
Completed NCT05828407 - Fluid Challenge Impact in the Portal Vein Pulsatility Depending on the Fluid Responsivness Status
Terminated NCT04086953 - Validation of a Walk-Time Limit Test (WTLT) Derived From the 6-Minute Walk Test (6-MWT) in Patients With Chronic Cardiovascular or Respiratory Diseases N/A